- 2024-08-20 02:03抑制剂MitoBloCK-11 (MB-11)|MitoBloCK-11 (MB-11)|413606-16-3|Adamas life|≥98%（以实测数值为准）|BR|25mg
- 2024-08-20 02:03抑制剂MitoBloCK-11 (MB-11)|MitoBloCK-11 (MB-11)|413606-16-3|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 02:03抑制剂Mirogabalin besylate|Mirogabalin besylate|1138245-21-2|Adamas life|≥98%（以实测数值为准）|BR|25mg
- 2024-08-20 02:03抑制剂Mirogabalin besylate|Mirogabalin besylate|1138245-21-2|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 02:03抑制剂Mito-apocynin (C11)|Mito-apocynin (C11)|1254044-38-6|Adamas life|≥98%（以实测数值为准）|BR|100mg
- 2024-08-20 02:03抑制剂Mito-apocynin (C11)|Mito-apocynin (C11)|1254044-38-6|Adamas life|≥98%（以实测数值为准）|BR|25mg
- 2024-08-20 02:03抑制剂Mirdametinib|Mirdametinib|391210-10-9|Adamas life|≥99%（以实测数值为准）|BR|5mg
- 2024-08-20 02:03抑制剂Mirogabalin besylate|Mirogabalin besylate|1138245-21-2|Adamas life|≥98%（以实测数值为准）|BR|100mg
- 2024-08-20 02:03抑制剂Mirdametinib|Mirdametinib|391210-10-9|Adamas life|≥99%（以实测数值为准）|BR|25mg
- 2024-08-20 02:03抑制剂Mirdametinib|Mirdametinib|391210-10-9|Adamas life|≥99%（以实测数值为准）|BR|100mg
- 2024-08-20 02:03抑制剂Militarine|Militarine|58139-23-4|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 02:03抑制剂Mimosine|Mimosine|500-44-7|Adamas life|≥98%（以实测数值为准）|BR|100mg
- 2024-08-20 02:03抑制剂Mimosine|Mimosine|500-44-7|Adamas life|≥98%（以实测数值为准）|BR|25mg
- 2024-08-20 02:03抑制剂MIK665|MIK665|1799631-75-6|Adamas life|≥98%（以实测数值为准）|BR|1mg
- 2024-08-20 02:03抑制剂MIK665|MIK665|1799631-75-6|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 02:03抑制剂Militarine|Militarine|58139-23-4|Adamas life|≥98%（以实测数值为准）|BR|1mg
- 2024-08-20 02:03抑制剂Militarine|Militarine|58139-23-4|Adamas life|≥98%（以实测数值为准）|BR|25mg
- 2024-08-20 02:02抑制剂MGH-CP1|MGH-CP1|896657-58-2|Adamas life|≥98%（以实测数值为准）|BR|100mg
- 2024-08-20 02:02抑制剂MGH-CP1|MGH-CP1|896657-58-2|Adamas life|≥98%（以实测数值为准）|BR|25mg
- 2024-08-20 02:02抑制剂MGH-CP1|MGH-CP1|896657-58-2|Adamas life|≥98%（以实测数值为准）|BR|5mg
